Create Medic Lifts Dividend as Profit Mix Shifts on Solid 2025 Sales

Create Medic Co., Ltd. ( (JP:5187) ) has provided an update.

Create Medic Co., Ltd., a Tokyo Standard-listed medical device manufacturer focused on hospital-use products, reported steady top-line growth for the year ended December 31, 2025, with net sales rising 4.5% to ¥13.6 billion. Operating profit jumped 45.1% to ¥1.0 billion and ordinary profit climbed 31.7%, although profit attributable to owners of parent fell 15.1%, reflecting factors such as a higher share count impact and other non-operating items, while equity strengthened with an 81.1% capital adequacy ratio.

The company lifted its annual dividend to ¥45 per share for 2025 from ¥39 a year earlier and projects another increase to ¥47 in 2026, signaling continued shareholder returns despite softer bottom-line profit in the latest year. For the fiscal year ending December 31, 2026, Create Medic forecasts modest growth, with net sales expected to rise 2.5% and profit attributable to owners of parent to improve 5.1%, indicating confidence in maintaining earnings momentum and a stable financial base under revised accounting standards.

The most recent analyst rating on (JP:5187) stock is a Buy with a Yen1306.00 price target. To see the full list of analyst forecasts on Create Medic Co., Ltd. stock, see the JP:5187 Stock Forecast page.

More about Create Medic Co., Ltd.

Create Medic Co., Ltd. is a Tokyo Standard-listed Japanese medical device maker specializing in urological and related disposable products. The company targets hospital and clinical markets in Japan and overseas, focusing on stable, profitability-oriented growth in niche medical fields.

Average Trading Volume: 9,264

Technical Sentiment Signal: Buy

Current Market Cap: Yen10.46B

Find detailed analytics on 5187 stock on TipRanks’ Stock Analysis page.